These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 21268027)
1. Evaluation of a non-Arrhenius model for therapeutic monoclonal antibody aggregation. Kayser V; Chennamsetty N; Voynov V; Helk B; Forrer K; Trout BL J Pharm Sci; 2011 Jul; 100(7):2526-42. PubMed ID: 21268027 [TBL] [Abstract][Full Text] [Related]
2. Predicting accelerated aggregation rates for monoclonal antibody formulations, and challenges for low-temperature predictions. Brummitt RK; Nesta DP; Roberts CJ J Pharm Sci; 2011 Oct; 100(10):4234-43. PubMed ID: 21671226 [TBL] [Abstract][Full Text] [Related]
3. Role of cosolutes in the aggregation kinetics of monoclonal antibodies. Nicoud L; Sozo M; Arosio P; Yates A; Norrant E; Morbidelli M J Phys Chem B; 2014 Oct; 118(41):11921-30. PubMed ID: 25243487 [TBL] [Abstract][Full Text] [Related]
4. Examination of thermal unfolding and aggregation profiles of a series of developable therapeutic monoclonal antibodies. Brader ML; Estey T; Bai S; Alston RW; Lucas KK; Lantz S; Landsman P; Maloney KM Mol Pharm; 2015 Apr; 12(4):1005-17. PubMed ID: 25687223 [TBL] [Abstract][Full Text] [Related]
5. Kinetics of Monoclonal Antibody Aggregation from Dilute toward Concentrated Conditions. Nicoud L; Jagielski J; Pfister D; Lazzari S; Massant J; Lattuada M; Morbidelli M J Phys Chem B; 2016 Apr; 120(13):3267-80. PubMed ID: 27007829 [TBL] [Abstract][Full Text] [Related]
6. Nonnative aggregation of an IgG1 antibody in acidic conditions, part 2: nucleation and growth kinetics with competing growth mechanisms. Brummitt RK; Nesta DP; Chang L; Kroetsch AM; Roberts CJ J Pharm Sci; 2011 Jun; 100(6):2104-19. PubMed ID: 21213307 [TBL] [Abstract][Full Text] [Related]
7. Transient molten globules and metastable aggregates induced by brief exposure of a monoclonal IgG to low pH. Filipe V; Kükrer B; Hawe A; Jiskoot W J Pharm Sci; 2012 Jul; 101(7):2327-39. PubMed ID: 22517069 [TBL] [Abstract][Full Text] [Related]
8. High Throughput Prediction Approach for Monoclonal Antibody Aggregation at High Concentration. Zidar M; Šušterič A; Ravnik M; Kuzman D Pharm Res; 2017 Sep; 34(9):1831-1839. PubMed ID: 28593474 [TBL] [Abstract][Full Text] [Related]
9. Kinetic analysis of the multistep aggregation mechanism of monoclonal antibodies. Nicoud L; Arosio P; Sozo M; Yates A; Norrant E; Morbidelli M J Phys Chem B; 2014 Sep; 118(36):10595-606. PubMed ID: 25119992 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of a dual-wavelength size exclusion HPLC method with improved sensitivity to detect protein aggregates and its use to better characterize degradation pathways of an IgG1 monoclonal antibody. Bond MD; Panek ME; Zhang Z; Wang D; Mehndiratta P; Zhao H; Gunton K; Ni A; Nedved ML; Burman S; Volkin DB J Pharm Sci; 2010 Jun; 99(6):2582-97. PubMed ID: 20039394 [TBL] [Abstract][Full Text] [Related]
11. Nonnative aggregation of an IgG1 antibody in acidic conditions: part 1. Unfolding, colloidal interactions, and formation of high-molecular-weight aggregates. Brummitt RK; Nesta DP; Chang L; Chase SF; Laue TM; Roberts CJ J Pharm Sci; 2011 Jun; 100(6):2087-103. PubMed ID: 21213308 [TBL] [Abstract][Full Text] [Related]
12. Structural properties of monoclonal antibody aggregates induced by freeze-thawing and thermal stress. Hawe A; Kasper JC; Friess W; Jiskoot W Eur J Pharm Sci; 2009 Sep; 38(2):79-87. PubMed ID: 19540340 [TBL] [Abstract][Full Text] [Related]
13. Understanding the Increased Aggregation Propensity of a Light-Exposed IgG1 Monoclonal Antibody Using Hydrogen Exchange Mass Spectrometry, Biophysical Characterization, and Structural Analysis. Bommana R; Chai Q; Schöneich C; Weiss WF; Majumdar R J Pharm Sci; 2018 Jun; 107(6):1498-1511. PubMed ID: 29408480 [TBL] [Abstract][Full Text] [Related]
14. Mechanically-induced aggregation of the monoclonal antibody cetuximab. Lahlou A; Blanchet B; Carvalho M; Paul M; Astier A Ann Pharm Fr; 2009 Sep; 67(5):340-52. PubMed ID: 19695370 [TBL] [Abstract][Full Text] [Related]
15. Conformational stability and aggregation of therapeutic monoclonal antibodies studied with ANS and Thioflavin T binding. Kayser V; Chennamsetty N; Voynov V; Helk B; Trout BL MAbs; 2011; 3(4):408-11. PubMed ID: 21540645 [TBL] [Abstract][Full Text] [Related]
16. Multi-variate approach to global protein aggregation behavior and kinetics: effects of pH, NaCl, and temperature for alpha-chymotrypsinogen A. Li Y; Ogunnaike BA; Roberts CJ J Pharm Sci; 2010 Feb; 99(2):645-62. PubMed ID: 19653264 [TBL] [Abstract][Full Text] [Related]
17. Global kinetic analysis of seeded BSA aggregation. Sahin Z; Demir YK; Kayser V Eur J Pharm Sci; 2016 Apr; 86():115-24. PubMed ID: 26970282 [TBL] [Abstract][Full Text] [Related]
18. Pre-study and in-study validation of a size-exclusion chromatography method with different detection modes for the analysis of monoclonal antibody aggregates. Oliva A; Fariña JB; Llabrés M J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():206-212. PubMed ID: 27107247 [TBL] [Abstract][Full Text] [Related]
19. Population balance modeling of antibodies aggregation kinetics. Arosio P; Rima S; Lattuada M; Morbidelli M J Phys Chem B; 2012 Jun; 116(24):7066-75. PubMed ID: 22594582 [TBL] [Abstract][Full Text] [Related]
20. Partial unfolding of a monoclonal antibody: role of a single domain in driving protein aggregation. Mehta SB; Bee JS; Randolph TW; Carpenter JF Biochemistry; 2014 May; 53(20):3367-77. PubMed ID: 24804773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]